Use of a multi-drug regimen gemcitabine, 5-fluorouracil, irinotecan, cisplatin, bevacizumab, docetaxel, and cyclophosphamide (GFIP/BDC) for heavily pretreated relapsed epithelial ovarian, fallopian tube and primary peritoneal cancer

BACKGROUND: Epithelial ovarian cancer has the highest fatality rate of all gynecologic malignancies. Although the majority of patients achieve complete clinical response after initial cytoreductive surgery and platinum-based chemotherapy, most recur and almost all will eventually acquire platinum-re...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, Samantha, Schwartz, Melissa, Dottino, Peter, Beddoe, Ann Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485135/
https://www.ncbi.nlm.nih.gov/pubmed/31027500
http://dx.doi.org/10.1186/s13048-019-0506-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485135/
https://www.ncbi.nlm.nih.gov/pubmed/31027500
http://dx.doi.org/10.1186/s13048-019-0506-4

Ejemplares similares